What is Passage Bio?

Passage Bio is a biotechnology company focused on developing gene therapies for rare, monogenic central nervous system (CNS) diseases. They use cutting-edge genetic technologies to create treatments that address the underlying causes of these disorders. The company collaborates with leading academic institutions and leverages advanced research to develop novel therapeutic candidates. Passage Bio’s mission is to provide life-changing therapies for patients with limited or no treatment options.